Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05946850
Other study ID # Salem2018 Caudal Blk Anticoag
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2, 2008
Est. completion date December 31, 2024

Study information

Verified date July 2023
Source Salem Anaesthesia Pain Clinic
Contact Olu Bamgbade, MD,FRCPC
Phone 17786286600
Email salem.painclinic@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Caudal analgesia is an effective intervention for lumbosacral pain. Some chronic pain patients take anticoagulants for vasculopathy treatment. Anticoagulation limits the use of caudal analgesia because of the risk of epidural bleeding. Caudal analgesia may be safe and effective in anticoagulated chronic pain patients. Quantitative analysis of prospective clinical data. Evaluation of caudal analgesia efficacy and safety in anticoagulated chronic pain patients. Analysis of outcome, and complications.


Description:

Caudal analgesia is an effective interventional therapy for chronic lumbosacral pain. Some chronic pain patients take anticoagulants for vasculopathy treatment. Anticoagulation limits the use of caudal analgesia because of the risk of epidural bleeding. Anticoagulation may be discontinued briefly, to allow caudal injection. Interruption of anticoagulation may be difficult and dangerous for some high-risk patients. Caudal analgesia may be safe and effective in anticoagulated chronic pain patients. Quantitative analysis of prospective clinical data. An evaluation of caudal analgesia safety in anticoagulated chronic pain patients. An analysis of treatment outcome, and complications.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 99 Years
Eligibility Inclusion Criteria: - adult chronic pain patients who undergo caudal analgesia Exclusion Criteria: - chronic pain patients who refuse caudal analgesia

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Caudal analgesia
Caudal analgesia for chronic lumbosacral pain

Locations

Country Name City State
Canada Salem Anaesthesia Pain Clinic Surrey British Columbia

Sponsors (1)

Lead Sponsor Collaborator
Salem Anaesthesia Pain Clinic

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJ, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA; ASIPP-IPM. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician. 2009 Jul-Aug;12(4):699-802. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain score, objective measurement using the validated Numeric Pain Rating scale Pain score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less pain, high scores indicate worse pain 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04517461 - Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery
Terminated NCT03296033 - Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin Phase 4
Recruiting NCT05123326 - Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
Completed NCT04074980 - Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test N/A
Completed NCT04505475 - Oral Surgery in Patients Taking Direct Oral Anticoagulants
Not yet recruiting NCT05997914 - Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation N/A
Recruiting NCT04329390 - MAC Project, Monitoring of AntiCoagulant Therapies (MAC)
Completed NCT03112525 - DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic
Not yet recruiting NCT06452342 - TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study Phase 4
Recruiting NCT03760874 - Atrial Fibrillation Research Database
Recruiting NCT04046029 - Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. Phase 4
Completed NCT04444700 - A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic Phase 3
Terminated NCT03566303 - Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis Phase 2/Phase 3
Not yet recruiting NCT04128254 - A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) Phase 4
Completed NCT05946863 - Caudal Block & Hip Fracture Surgery in Anticoagulated Patient
Recruiting NCT05545475 - Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
Completed NCT06269302 - Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
Active, not recruiting NCT04676880 - Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy N/A
Completed NCT05224388 - Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Completed NCT03871283 - Anticoagulation and Antiplatelet Management During Perioperative Period